Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Nucleic Acids Res ; 42(6): e48, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24445804

RESUMO

A conditional gene expression system that is fast-acting, is tunable and achieves single-gene specificity was recently developed for yeast. A gene placed directly downstream of a modified GAL1 promoter containing six Zif268 binding sequences (with single nucleotide spacing) was shown to be selectively inducible in the presence of ß-estradiol, so long as cells express the artificial transcription factor, Z3EV (a fusion of the Zif268 DNA binding domain, the ligand binding domain of the human estrogen receptor and viral protein 16). We show the strength of Z3EV-responsive promoters can be modified using straightforward design principles. By moving Zif268 binding sites toward the transcription start site, expression output can be nearly doubled. Despite the reported requirement of estrogen receptor dimerization for hormone-dependent activation, a single binding site suffices for target gene activation. Target gene expression levels correlate with promoter binding site copy number and we engineer a set of inducible promoter chassis with different input-output characteristics. Finally, the coupling between inducer identity and gene activation is flexible: the ligand specificity of Z3EV can be re-programmed to respond to a non-hormone small molecule with only five amino acid substitutions in the human estrogen receptor domain, which may prove useful for industrial applications.


Assuntos
Regulação Fúngica da Expressão Gênica , Engenharia Genética , Saccharomyces cerevisiae/genética , Regiões 5' não Traduzidas , Sítios de Ligação , Estradiol/farmacologia , Galactoquinase/genética , Ligantes , Regiões Promotoras Genéticas , Receptores de Estrogênio/metabolismo , Saccharomyces cerevisiae/metabolismo , Proteínas de Saccharomyces cerevisiae/genética , Biologia Sintética/métodos , Fatores de Transcrição/metabolismo
2.
Bioorg Med Chem Lett ; 18(22): 5864-6, 2008 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-18595692

RESUMO

A derivative of rhodamine 110 has been designed and assessed as a probe for cytochrome P450 activity. This probe is the first to utilize a 'trimethyl lock' that is triggered by cleavage of an ether bond. In vitro, fluorescence was manifested by the CYP1A1 isozyme with k(cat)/K(M)=8.8x10(3)M(-1)s(-1) and K(M)=0.09microM. In cellulo, the probe revealed the induction of cytochrome P450 activity by the carcinogen 2,3,7,8-tetrachlorodibenzo-p-dioxin, and its repression by the chemoprotectant resveratrol.


Assuntos
Citocromo P-450 CYP1A1/metabolismo , Sistema Enzimático do Citocromo P-450/análise , Corantes Fluorescentes , Dibenzodioxinas Policloradas/farmacologia , Rodaminas/síntese química , Sistema Enzimático do Citocromo P-450/metabolismo , Humanos , Isoenzimas , Estrutura Molecular , Pró-Fármacos/farmacologia , Resveratrol , Rodaminas/farmacologia , Estilbenos/farmacologia , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA